Expertise in
16
conditions

Qing Y. Xie-Zhang

197 Ruijin 2nd Road, 
Shanghai, CN 
Expertise in
16
conditions
197 Ruijin 2nd Road, 
Shanghai, CN 

Overview

Qing Xie-Zhang practices practicing medicine in Shanghai, China.

Xie-Zhang is highly rated in 16 conditions, according to our data. Their clinical expertise encompasses Hepatitis B, Hepatitis, Liver Failure, Liver Transplant, and Endoscopy.

They are actively involved in clinical research, co-authoring 828 peer reviewed articles and participating in 3 clinical trials.

Locations

197 Ruijin 2nd Road, Shanghai, 200025, China
Other Locations
197 Ruijin Er Road, Huangpu, 200025, China
No. 15 Yuquan Road, Yuquan, 100049, China
215 Guangzhou Road, Nanjing, 210029, China
227 South Chongqing Road, 20025, Shanghai, China
Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
38 Xue Yuan Road, Haidian, 100191, China
Ruijin Second Road 197, Huangpu, China
12# Wu Lu Mu Qi Road, Shanghai, 200040, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase IIb Multi-Center, Randomised, Open Label Study to Assess the Efficacy and Safety of Sequential Treatment With GSK3228836 Followed by Pegylated Interferon Alpha 2a in Participants With Chronic Hepatitis B Virus (B-Together)
A Phase IIb Multi-Center, Randomised, Open Label Study to Assess the Efficacy and Safety of Sequential Treatment With GSK3228836 Followed by Pegylated Interferon Alpha 2a in Participants With Chronic Hepatitis B Virus (B-Together)
Enrollment Status: Completed
Publish Date: May 02, 2024
Intervention Type: Drug
Study Drugs: GSK3228836, PegIFN, NA therapy
Study Phase: Phase 2
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Combination product
A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
Enrollment Status: Completed
Publish Date: October 01, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

828 Total Publications

Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism.
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism.
Journal: Cell metabolism
Published: July 22, 2026

Frequently Asked Questions about Qing Y. Xie-Zhang

Is Qing Y. Xie-Zhang a top-rated expert for Hepatitis B?

MediFind is an objective health platform that identifies experts based on real-world data. Qing Y. Xie-Zhang is classified as an Elite expert for Hepatitis B, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Qing Y. Xie-Zhang participate in research or clinical trials?

Yes. Qing Y. Xie-Zhang has published 828 articles and abstracts on conditions like Hepatitis B. You can view a list of Qing Y. Xie-Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xie-Zhang's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 78 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile